Skip to main content
ESTABLISHMENT LABS HOLDINGS INC. logo

ESTABLISHMENT LABS HOLDINGS INC. — Investor Relations & Filings

Ticker · ESTA ISIN · VGG312491084 LEI · 549300BCBQ714JNJ7V58 US Manufacturing
Open in API
Filings indexed 500 across all filing types
Latest filing 2026-05-22 Declaration of Voting R…
Country VG Virgin Islands (British)
Listing US ESTA

About ESTABLISHMENT LABS HOLDINGS INC.

https://establishmentlabs.com

Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women's health and wellness through science, engineering, and technology. The company designs, develops, manufactures, and markets a portfolio of Femtech solutions for breast health, aesthetics, and reconstruction. Its principal products include the Motiva® line of silicone breast implants, such as the SmoothSilk® Round and Ergonomix® models, which are recognized for their safety profiles. The portfolio also features the Motiva Flora® tissue expander for breast reconstruction and Mia Femtech™, a minimally invasive experience for breast harmony. The company's innovation is supported by extensive clinical evidence, numerous scientific publications, and a robust portfolio of over 200 patent applications.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Form 8-K “Current Report” under Item 5.07 “Submission of Matters to a Vote of Security Holders” and provides detailed shareholder voting results for proposals (director elections, advisory compensation vote, auditor ratification). These are official results of a shareholder vote. Therefore this is a Declaration of Voting Results & Voting Rights Announcement.
2026-05-22 English
8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
Earnings Release Classification · 98% confidence The document is a Form 8-K filed with the SEC under Item 2.02 “Results of Operations and Financial Condition,” indicating that the company issued a press release announcing quarterly financial results for the period ended March 31, 2026. This matches the definition of an Earnings Release (ER) as the initial announcement of periodical financial results. Hence, this filing should be classified as ER. Q1 2026
2026-05-06 English
8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text details the entry into a material definitive agreement, specifically an amended credit agreement involving term loans and financing terms. It includes detailed descriptions of the loan amounts, interest rates, covenants, and other financing terms. The document is not a full financial report but rather an announcement of a financing event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is 9739 characters, which is substantial and contains detailed information about the financing agreement, not just a brief announcement or reference to another report. Therefore, the appropriate classification is CAP with high confidence.
2026-04-30 English
DEF 14A - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
Proxy Solicitation & Information Statement
2026-04-10 English
4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
Director's Dealing
2026-03-28 English
4 - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Issuer)
Director's Dealing
2026-03-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.